نتائج البحث - Hee‐Je Kim

تنقيح النتائج
  1. 1
    Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside

    Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside حسب Byung-Sik Cho, Hee‐Je Kim, Marina Konopleva

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy

    Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy حسب Sung‐Yeon Cho, Dong‐Gun Lee, Hee‐Je Kim

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Characteristics of<i>DNMT3A</i>mutations in acute myeloid leukemia

    Characteristics of<i>DNMT3A</i>mutations in acute myeloid leukemia حسب Dong Jin Park, Ahlm Kwon, Byung‐Sik Cho, Hee‐Je Kim, Kyung-Ah Hwang, Myungshin Kim, Yonggoo Kim

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

    Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia حسب Hee‐Je Kim, Yonggoo Kim, Dain Kang, Hoon Seok Kim, Jong‐Mi Lee, Myungshin Kim, Byung‐Sik Cho

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patients

    Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patients حسب Yonggoo Kim, Dong Wook Jekarl, Jiyeon Kim, Ahlm Kwon, Hayoung Choi, Seungok Lee, Yoo‐Jin Kim, Hee‐Je Kim, Yonghwan Kim, Il‐Hoan Oh, Myungshin Kim

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia

    The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome–positive acute lymph... حسب Seok Lee, Yoo‐Jin Kim, Chang‐Ki Min, Hee‐Je Kim, Ki‐Sung Eom, Dong-Wook Kim, Jong‐Wook Lee, Woo-Sung Min, Chun-Choo Kim

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently

    TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently حسب Han Sun Kim, Bo-Reum Kim, Thien T. P. Dao, Jinmo Kim, Yoon-Ju Kim, Hyunsong Son, Sihyang Jo, Doyeon Kim, Jiwoo Kim, Young Ju Suh, Hee‐Je Kim, Byung‐Sik Cho, Sunghyouk Park

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy

    Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy حسب Jae‐Ho Yoon, Sung‐Soo Park, Young‐Woo Jeon, Sung‐Eun Lee, Byung-Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Jong Wook Lee

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation

    Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation حسب Byung‐Sik Cho, Seung‐Ah Yahng, Sung‐Eun Lee, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Dong-Wook Kim, Jong‐Wook Lee, Woo-Sung Min, Chong-Won Park

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates

    WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and... حسب Byung‐Sik Cho, Gi June Min, Sungsu Park, Seung‐Hwan Shin, Seung‐Ah Yahng, Young‐Woo Jeon, Jae‐Ho Yoon, Sung‐Eun Lee, Ki‐Seong Eom, Yoo‐Jin Kim, Seok Lee, Chang‐Ki Min, Seok‐Goo Cho, Dong‐Wook Kim, Jong‐Wook Lee, Myungsin Kim, Young-Gu Kim, Hee‐Je Kim

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Follow-up of patients with R/R <i>FLT3-</i>mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

    Follow-up of patients with R/R <i>FLT3-</i>mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial حسب Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev, Stephen A. Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Récher, Sung‐Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee‐Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramón V. Tiu, Mark J. Levis

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

    DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Tr... حسب Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, Seun-Shin Lee, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Nan Young Kim, Seung Hyun Choi, Chul Won Jung, Jun‐Ho Jang, Hee‐Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung‐Hyun Kim, Dennis Dong Hwan Kim

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease

    Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease حسب Sung‐Eun Lee, Ji‐Young Lim, Da‐Bin Ryu, Tae‐Woo Kim, Sung Soo Park, Young‐Woo Jeon, Jae‐Ho Yoon, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Seok‐Goo Cho, Dong‐Wook Kim, Jong Wook Lee, Chong-Su Kim, Dong‐Mi Shin, Chang‐Ki Min

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy

    Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Che... حسب Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev, Stephen A. Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Récher, Sung‐Soo Yoon, Yoshinobu Maeda, Naoko Hosono, Masahiro Onozawa, Takayasu Kato, Hee‐Je Kim, Nahla Hasabou, Rishita Nuthethi, Ramón V. Tiu, Mark J. Levis

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3–internal tandem duplications in the QuANTUM-First trial

    Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3–internal tandem duplications in... حسب Richard F. Schlenk, Pau Montesinos, Hee‐Je Kim, Antonio Romero-Aguilar, Radovan Vrḫovac, Elżbieta Patkowska, Павел Зак, Po‐Nan Wang, James Hanyok, Li Liu, Yasser Mostafa Kamel, Karima Imadalou, Arnaud Lesegretain, Jorge E. Cortés, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Alexander E. Perl, Mark J. Levis, Harry P. Erba

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Enasidenib vs conventional care in older patients with late-stage mutant-<i>IDH2</i> relapsed/refractory AML: a randomized phase 3 trial

    Enasidenib vs conventional care in older patients with late-stage mutant-<i>IDH2</i> relapsed/refractory AML: a randomized phase 3 trial حسب Stéphane de Botton, Pau Montesinos, Andre C. Schuh, Cristina Papayannidis, Paresh Vyas, Andrew H. Wei, Hans Beier Ommen, С. В. Семочкин, Hee‐Je Kim, Richard A. Larson, Jaime Koprivnikar, Olga Frankfurt, Felicitas Thol, Jörg Chromik, Jenny Byrne, Arnaud Pigneux, Xavier Thomas, Olga Salamero, María‐Belén Vidriales, Vadim Doronin, Hartmut Döhner, Amir T. Fathi, Eric Laille, Xin Yu, Maroof Hasan, Patricia Martín-Regueira, Courtney D. DiNardo

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia

    Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia حسب Ga‐Young Song, Hyeon-Jong Kim, Tae‐Hyung Kim, Seo‐Yeon Ahn, Sung‐Hoon Jung, Mihee Kim, Deok‐Hwan Yang, Je‐Jung Lee, Mi Yeon Kim, June‐Won Cheong, Chul Won Jung, Jun Ho Jang, Hee‐Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Seong Kyu Park, Sung‐Hyun Kim, Chang Kyun Choi, Hyeoung‐Joon Kim, Jae‐Sook Ahn, Dennis Dong Hwan Kim

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML

    Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML حسب Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K. Singh, Mark R. Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Üstün, Masumi Ueda, Geoffrey L. Uy, Edmund K. Waller, Sumithira Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee‐Je Kim, Matthias Stelljes, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Caroline Chen, Nahla Hasabou, Matt Rosales, Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

    An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia حسب Molly C. Tokaz, Helen Baldomero, Andrew J. Cowan, Wael Saber, Hildegard Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastián Galeano, Shinichiro Okamoto, Naeem Chaudhri, Amado Karduss, Fabio Ciceri, Vergílio Antonio R. Colturato, Selim Corbacioglu, Alaa Elhaddad, Lisa M. Force, Cristóbal Frutos, Andrés Gómez‐De León, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius Ho, Xiao‐Jun Huang, Ben Jacobs, Hee‐Je Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary‐Elizabeth M. Percival, Martina Perdomo, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor‐Sheng Ko, Anderson João Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A. Snowden, Daniel J. Weisdorf, Jakob Passweg, Marcelo C. Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

    An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia حسب Molly C. Tokaz, Helen Baldomero, Andrew J. Cowan, Wael Saber, Hildegard Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastián Galeano, Shinichiro Okamoto, Naeem Chaudhri, Amado Karduss, Fabio Ciceri, Vergílio R. Colturato, Selim Corbacioglu, Alaa Elhaddad, Lisa M. Force, Cristobal Augusto Frutos Ortiz, Andrés Gómez‐De León, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius Ho, Xiao‐Jun Huang, Benjamin Jacobs, Hee‐Je Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary‐Elizabeth M. Percival, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor‐Sheng Ko, Anderson João Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A. Snowden, Daniel J. Weisdorf, Jakob Passweg, Marcelo C. Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser, Martina Perdomo

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: